Last Updated on May 11, 2022 by The Health Master
Download the notification, link given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 84 drug formulations for various diseases.
“NPPA has fixed retail prices of 66 formulations under Drugs (Prices Control) Order, 2013 (DPCO) vide notification No. S.O. 2164(E) dated 09-05-2022.
“NPPA has fixed retail prices of 18 formulations under Drugs (Prices Control) Order, 2013 (DPCO) vide notification No. S.O. 2165(E) dated 09-05-2022.
“NPPA has also revised retail price of 1 formulation under Drugs (Prices Control) Order, 2013 (DPCO) vide notification No. S.O. 2166(E) dated 09-05-2022, .
(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of
the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is
payable to the Government on the retail price mentioned in column (6) of the above said
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned
manufacturer in accordance with the retail price specified in column (6) of the above table
as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall
issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO,
2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the
supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of
the premises where he carries on business in a manner so as to be easily accessible to any
person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer /
marketer as mentioned above i.e. who have applied for the same by submitting Form-I for
price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the
applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules,
including manufacturing license permission from the Competent Authority i.e. the
Central/State Licensing Authority, as may be applicable, by the concerned
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per
instant price notification and notes specified hereinabove, then the concerned
manufacturer/marketing company shall be liable to deposit the overcharged amount along
with the interest thereon under the provisions of the DPCO, 2013 read with the Essential
Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued
prior to the above said date of notification, stand(s) superseded.
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon: